je.st
news
Tag: strategies
Headwinds in Venture Funding: Strategies for Companies in 2016
2016-03-12 06:48:25| IT Services - Topix.net
By all measures, much of 2014 and 2015 were strong years in venture capital funding. The current forecast is, however, less optimistic for founders looking for venture backing; the end of 2015 saw a pullback in private investing and trends for the start of 2016 demonstrate caution among investors.
Tags: in
companies
strategies
funding
GM and Ford Move to Expand Driverless Car Strategies
2016-03-11 21:41:06| Furniture - Topix.net
San Franciso-based Cruise, founded in 2013, has a permit from California to test driverless cars and is funded with about $20 million in venture capital. , announced it created a subsidiary called Ford Smart Mobility and named a Ford director, James Hackett, as head of the unit.
Tags: car
move
expand
strategies
3 Strategies for MedTech Manufacturers to Maximize Profits in 2016
2016-03-11 11:31:12| Industrial Newsroom - All News for Today
By Steve Bieszczat, Chief Marketing Officer; Ed Potoczak, Industry Manager; IQMS If the latest report by the Institute for Supply Management (ISM)* is right, 2016 will be a bright one with a projected 4.1% net increase in manufacturing revenues. Yet many contract manufacturers and parts suppliers within the medical...
Tags: in
strategies
manufacturers
profits
Investors See Opportunity in Value-Add Strategies for Class-B Multifamily Assets
2016-03-08 17:10:00| National Real Estate Investor
As fewer renters can afford class-A apartment units, developers can capitalize by upgrading class-B and class-C properties. read more
Tags: opportunity
strategies
assets
investors
Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies
2016-03-08 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & LYON, France KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue their own distinct growth strategies in Europe. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more
Sites : [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] next »